CACNA1A is a gene encoding the alpha-1 subunit of the CaV2.1 calcium channel. This channel allows calcium ions to enter the cell and helps facilitate muscle contraction and neurotransmitter release, among other functions. The effects of specific mutations in CACNA1A can be ascertained by introducing a replica of the gene containing a particular mutation into cells and then measuring the electrical activities of those cells.
We are pleased to offer our mutation characterization and drug screening services for eligible pathogenic mutations within CACNA1A at the current rate of $50,000 and an anticipated timeline of six months. Please contact us with interests and inquiries.